acetic acid has been researched along with orlistat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fujibayashi, Y; Fukumura, T; Furukawa, T; Hasegawa, Y; Kiyono, Y; Lewis, JS; Nishii, R; Oyama, N; Saga, T; Sogawa, C; Tsuji, AB; Waki, A; Wakizaka, H; Yoshii, H; Yoshii, Y | 1 |
2 other study(ies) available for acetic acid and orlistat
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
Topics: Acetic Acid; Adenocarcinoma; Animals; Antineoplastic Agents; Biological Transport; Carbon Radioisotopes; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Gene Expression; Gene Expression Profiling; Humans; Lactones; Male; Mice; Mice, Inbred NOD; Molecular Targeted Therapy; Neoplasms, Experimental; Orlistat; Prostatic Neoplasms; RNA, Small Interfering | 2013 |